Pharmaceuticals
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Trend Stats
1-Month Return
-1.28%
3-Month Return
-5.65%
12-Month Return
+13.02%
Volatility Score
1.6
RSI
34.4
ST Trend
Down
LT Trend
Neutral
Short-Term Trend
Down
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Neutral
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Pharmaceuticals
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | $781B | -4.61% | -16.75% | -3.08% | 3.3 | Down | Down |
| JNJ | Johnson&Johnson | $548B | +49.50% | +0.56% | -5.45% | 2.1 | Down | Up |
| ABBV | AbbVie | $350B | +7.91% | -6.74% | -1.82% | 2.7 | Down | Down |
| AZN | ASTRAZENECA | $290B | +162.47% | +102.10% | -1.71% | 2.2 | Down | Up |
| NVS | Novartis Sp ADR | $278B | +29.76% | -1.11% | -3.54% | 1.8 | Down | Up |
| MRK | Merck | $272B | +34.95% | +3.17% | -7.26% | 2.7 | Down | Up |
| NVO | Nordisk Sp ADR-B | $183B | -36.54% | -29.72% | +15.70% | 3.0 | Up | Down |
| PFE | Pfizer | $151B | +15.39% | +0.61% | -2.88% | 2.1 | Down | Up |
| BMY | Bristol-MyersSqu | $119B | +20.45% | +7.19% | -0.61% | 2.3 | Down | Up |
| SNY | SANOFI SP ADR | $110B | -12.55% | -0.37% | -1.60% | 1.8 | Down | Down |
| GSK | GSK Sp ADR | $109B | +34.19% | +2.26% | -4.53% | 2.5 | Down | Up |
| MCK | Mckesson | $102B | +15.87% | +0.12% | -4.36% | 2.1 | Down | Neutral |
| COR | Cencora | $61B | +7.17% | -11.40% | -0.33% | 2.4 | Down | Down |
| TAK | TAKEDA PHARM SP ADR | $52B | +9.01% | -5.07% | -8.99% | 1.9 | Down | Up |
| ZTS | Zoetis-A | $49B | -26.09% | -6.08% | +0.86% | 2.6 | Down | Down |
| HLN | Haleon Sp ADR | $42B | -6.59% | -8.51% | -3.85% | 1.6 | Down | Down |
| TEVA | TEVAPHARMIND SP ADR | $37B | +128.11% | +6.99% | +23.10% | 3.2 | Up | Up |
| VTRS | Viatris | $17B | +86.08% | +15.52% | +14.71% | 2.6 | Up | Up |
| JAZZ | Jazz Pharmaceuti | $13B | +70.93% | +21.92% | +9.43% | 2.7 | Up | Up |
| ELAN | ELANC ANIML HLTH | $11B | +129.96% | -9.92% | -5.75% | 4.1 | Down | Neutral |
| AXSM | Axsome Therapeut | $9.5B | +63.82% | -0.71% | +17.65% | 3.5 | Up | Up |
| MIDD | Middleby Corp | $6.6B | +4.12% | -7.43% | +7.94% | 3.5 | Down | Down |
| CORT | Corcept Therapeu | $5B | -35.18% | +4.44% | +23.91% | 3.8 | Up | Down |
| OGN | Organon | $3.5B | +4.17% | +55.50% | +128.42% | 6.0 | Up | Up |
| BHC | BAUSCH HEALTH | $2.1B | +5.47% | +0.00% | +11.35% | 3.6 | Neutral | Down |
| PRGO | Perrigo | $1.6B | -53.06% | -15.99% | +18.47% | 4.5 | Neutral | Down |
| 0 | 0 | 0 | 0 | Bullish | Bullish |
